Search
Search Results
##search.searchResults.foundPlural##
-
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3813Suppl. Files: 1075PDF: 1039Html: 157 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4737PDF: 1733HTML: 2692Untitled: 199 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1257PDF: 995HTML: 111 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1525PDF: 867HTML: 971figures: 165table 1: 171table2: 168table3: 169 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4197PDF: 1154HTML: 2136Figure 1: 152 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1714PDF: 512HTML: 16961Figure 4: 154Figure 3: 130Figure 2: 132Figure 1: 161 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1894PDF: 1140HTML: 258 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1547PDF: 833HTML: 1025Picture 1: 156 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3829PDF: 1453HTML: 8500 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1114PDF: 892HTML: 282 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1358PDF: 805HTML: 3109 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1347PDF: 1281HTML: 84 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3698PDF: 1436HTML: 470Figures . Eliassian: 208 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
1813PDF: 1031HTML: 222 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1793PDF: 815HTML: 1564 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2457PDF: 828HTML: 8800Efremov 1: 209Efremov 2: 171 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
1998PDF: 1835HTML: 336 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
722PDF: 532Suppl. Files: 117HTML: 81 -
Stroke in a patient with tuberculous meningitis and HIV infection
1555PDF: 785HTML: 1715figure 1: 145 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1135PDF: 809HTML: 2166Figue 1: 164 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
1997PDF: 774HTML: 1012 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2349PDF: 986HTML: 1637Fig 1: 171Tab I: 198Cover Letter: 190 -
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts COVID-19 in cancer patients
1161PDF: 765HTML: 207 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2549PDF: 1584HTML: 2344Table1: 181 -
-
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3628PDF: 1407HTML: 172







